This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Jorgen Petersen: Innovator in Monoclonal Antibody Development
Introduction
Jorgen Petersen is a notable inventor in the field of biotechnology, particularly known for his work on human monoclonal antibodies. His contributions have significantly advanced the understanding and treatment of various diseases through innovative antibody-based therapies.
Latest Patents
Jorgen Petersen holds a patent for "Human Monoclonal Antibodies Against CD20." This patent describes an isolated human monoclonal antibody that binds to human CD20, comprising specific sequences for variable heavy (VH) and light (VL) chains. The patent also details antibodies that compete for binding to an epitope on human CD20, along with cells producing these antibodies, compositions that include them, and their therapeutic and diagnostic uses.
Career Highlights
Throughout his career, Jorgen Petersen has worked with prominent companies in the biotechnology sector, including Genmab A/S and Cormorant Pharmaceuticals AB. His work has focused on developing innovative solutions in the field of monoclonal antibodies, contributing to advancements in medical treatments.
Collaborations
Jorgen has collaborated with notable professionals in his field, including Jessica Teeling and Sigrid Ruuls. These collaborations have further enhanced his research and development efforts in monoclonal antibody technology.
Conclusion
Jorgen Petersen's work in the development of human monoclonal antibodies has made a significant impact in biotechnology. His innovative approaches continue to pave the way for new therapeutic options in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile